Press releaseGlobe Newswire
Avenue Therapeutics
ATXI · OTC
$0.4042−$0.0258 (−6.00%)TodayMarket closed ·
No price history for this range.
Latest news
- Press releaseGlobe Newswire
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy
- Press releaseGlobe Newswire
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
- News
Avenue Therapeutics Q2 EPS $0.11 Up From $(6.43) YoY, Sales $1.404M
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
Avenue Therapeutics Q3 EPS $(1.92) Misses $(0.94) Estimate
- Press releaseGlobe Newswire
Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
- NewsAvi Kapoor
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
- Press releaseGlobe Newswire
Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.